Contacting EMA: post-authorisation

Notifying EMA of changes to contact persons (veterinary medicines)

Referral: Tecovirimat SIGA, tecovirimat Article 20 procedures European Commission final decision, 26/03/2026, 29/05/2026, 15/06/2026

Human medicines European public assessment report (EPAR): Tecovirimat SIGA, tecovirimat monohydrate, Date of authorisation: 06/01/2022, Revision: 6, Status: Authorised

Committee for Medicinal Products for Veterinary Use (CVMP): 10-12 March 2026, European Medicines Agency, Amsterdam, the Netherlands, from 10 March 2026 to 12 March 2026

EMA Management Board: highlights of June 2026 meeting

Human medicines European public assessment report (EPAR): Sitagliptin / Metformin hydrochloride Mylan, sitagliptin hydrochloride monohydrate,metformin hydrochloride, Date of authorisation: 16/02/2022, Revision: 7, Status: Authorised

Human medicines European public assessment report (EPAR): Tadalafil Mylan, tadalafil, Date of authorisation: 21/11/2014, Revision: 19, Status: Authorised

Lonquex : EPAR - Public assessment report

Human medicines European public assessment report (EPAR): Efavirenz/Emtricitabine/Tenofovir disoproxil Mylan, efavirenz,emtricitabine,tenofovir disoproxil, Date of authorisation: 05/09/2017, Revision: 19, Status: Authorised